Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy
Korean Circulation Journal
;
: 1097-1119, 2018.
Article
in English
| WPRIM
| ID: wpr-738672
ABSTRACT
Although elevated serum low-density lipoprotein-cholesterol (LDL-C) is without any doubts accepted as an important risk factor for cardiovascular disease (CVD), the role of elevated triglycerides (TGs)-rich lipoproteins as an independent risk factor has until recently been quite controversial. Recent data strongly suggest that elevated TG-rich lipoproteins are an independent risk factor for CVD and that therapeutic targeting of them could possibly provide further benefit in reducing CVD morbidity, events and mortality, apart from LDL-C lowering. Today elevated TGs are treated with lifestyle interventions, and with fibrates which could be combined with omega-3 fatty acids. There are also some new drugs. Volanesorsen, is an antisense oligonucleotid that inhibits the production of the Apo C-III which is crucial in regulating TGs metabolism because it inhibits lipoprotein lipase (LPL) and hepatic lipase activity but also hepatic uptake of TGs-rich particles. Evinacumab is a monoclonal antibody against angiopoietin-like protein 3 (ANGPTL3) and it seems that it can substantially lower elevated TGs levels because ANGPTL3 also regulates TGs metabolism. Pemafibrate is a selective peroxisome proliferator-activated receptor alpha modulator which also decreases TGs, and improves other lipid parameters. It seems that it also has some other possible antiatherogenic effects. Alipogene tiparvovec is a nonreplicating adeno-associated viral vector that delivers copies of the LPL gene to muscle tissue which accelerates the clearance of TG-rich lipoproteins thus decreasing extremely high TGs levels. Pradigastat is a novel diacylglycerol acyltransferase 1 inhibitor which substantially reduces extremely high TGs levels and appears to be promising in treatment of the rare familial chylomicronemia syndrome.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Triglycerides
/
Cardiovascular Diseases
/
Fatty Acids, Omega-3
/
Risk Factors
/
Mortality
/
PPAR alpha
/
Diacylglycerol O-Acyltransferase
/
Apolipoprotein C-III
/
Fibric Acids
/
Life Style
Type of study:
Etiology study
/
Prognostic study
/
Risk factors
Language:
English
Journal:
Korean Circulation Journal
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS